High dose group:2.72g/d Mang-Ji-Shi Capsule
Sponsors
Beijing Chinese Medicine Hospital affiliated to Capital Medical University
Conditions
Primary hyperlipidemia
Phase 2
A randomized, double-blind, dose-exploratory, placebo parallel-controlled, multicenter phase II clinical trial to evaluate the safety and efficacy of Mang-Ji-Shi capsule in the treatment of primary hyperlipidemia
RecruitingChiCTR2000035594
Start: 2020-08-01Updated: 2020-08-17
A randomized, double-blind, dose-exploratory, placebo parallel-controlled, multicenter phase II clinical trial to evaluate the safety and efficacy of Mang-Ji-Shi capsule in the treatment of primary hyperlipidemia
RecruitingITMCTR2000003563
Start: 2020-08-01Updated: 2023-02-20